Purchase Order 75F40118P10291
Award Date 8/28/18
Potential Completion Date 8/31/19
Potential Value $89K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Liberty, IA 52317, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories. The $84,150 contract is for services to further elucidate the antimicrobial resistance pharmacogenetic relationships for select organisms and drug/drug classes, in order to advance regulatory science and public health. The work supports the FDA's efforts to address critical challenges...
- The Department of Health and Human Services Food and Drug Administration awarded a $148,940 firm-fixed-price purchase order contract to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, to conduct research on elucidating antimicrobial resistance pharmacogenetic relationships for organisms and drug/drug classes of critical/serious concern. This work is intended to advance regulatory science and public health. The contract, which has a completion date of June 30,...
- This federal contract award is for antimicrobial resistance laboratory services with the Food and Drug Administration (FDA). The $1,122,383.45 definitive contract, with a firm fixed price, was awarded to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, a for-profit Subchapter S Corporation. The contract is an option exercise and contract officer representative change to an existing contract. JMI Laboratories is a microbiology specialist company that provides a...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $14,311 firm fixed-price delivery order to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, on July 22, 2019. This task order, designated Task A06, requires JMI Laboratories to determine the in vitro minimum inhibitory concentration (MIC) of a candidate antimicrobial product against a panel of Listeria monocytogenes clinical isolates. The work will be performed in North Liberty, Iowa, with...
- Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, was awarded a $76,000 delivery order on January 11, 2019, under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite-delivery/indefinite-quantity contract vehicle. The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, funded this civilian contract to conduct in vitro assessments of antimicrobial activity against bacterial species....
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $159,000 delivery order to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, for in vitro testing to determine the inhibitory effects of experimental antibacterial substances against bacterial pathogens. The contract, which was awarded on August 4, 2023, with an ultimate completion date of August 3, 2024, operates under a firm fixed-price structure with no small business set-aside...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $755.7K delivery order to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, on September 16, 2021, with completion targeted for September 15, 2022. Under this firm fixed-price contract, JMI Laboratories will determine the in vitro inhibitory effect of experimental antibacterial substances against bacterial pathogens using minimum inhibitory concentration (MIC) testing methodologies. The...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $981.3k to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, on June 21, 2019. This task order, designated A02, falls under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite-delivery/indefinite-quantity contract vehicle and supports screening of natural product libraries for antimicrobial activity. The contract utilizes cost-plus-fixed-fee...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $195.7K delivery order to Element Materials Technology Iowa City Inc., operating as JMI Laboratories, for in vitro screening of antibacterial activity against public health disease pathogens. The contract, which was awarded on April 21, 2022, with an ultimate completion date of May 1, 2023, is structured as a firm fixed-price delivery order under the In Vitro Assessments of Antimicrobial Activity (IVAAA)...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $112.4K delivery order contract to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, on August 14, 2024, with completion expected by August 13, 2025. This firm fixed-price contract supports in vitro screening for antibacterial activity against public health disease pathogens and determination of the in vitro inhibitory effect of experimental antibacterial substances against bacterial...